WASHINGTON–( )– The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO.
Established Industry Leader Rachel King will Serve as BIO’s Interim LeaderWASHINGTON (BUSINESS WIRE) The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members announced today that Rachel King, co-founder and former CEO of GlycoMimet.